1/2 A Phase 2 Study of Elafin (Tiprelestat) for the Treatment of Pulmonary Arterial Hypertension (PAH)
Clinical Trial Grant
Administered By
Medicine, Cardiology
Awarded By
Stanford University
Start Date
August 15, 2025
End Date
July 31, 2026
Administered By
Medicine, Cardiology
Awarded By
Stanford University
Start Date
August 15, 2025
End Date
July 31, 2026